The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/19076
StudyName: Eligibility Pulmonary Arterial Hypertension NCT00423202
Date of export from the portal: 02.07.2020
Date of Upload / last change: 04.12.2016
License: Creative Commons BY 4.0

----

Description: 
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.; ODM derived from: https://clinicaltrials.gov/show/NCT00423202
